Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol with Early Behavioral Intervention in ASD
NCT02428205Completed
- Sponsor
- University of Missouri
- Start
- Apr 2015
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Propranolol arm with Placebo arm (2 arms). Primary endpoints: General Social Outcome Measure at 12 weeks and Social Responsiveness Scale at 12 weeks. Started Apr 2015; status: completed.
02
Drugs
propranolol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02428205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428205.